Your pills do not look like the brand name medication. The pills I have received have a different name printed on them. Why?
As we have already mentioned that no manufacturer can take out a patent for a chemical agent. Thus generics can have the exactly same active ingredients as the brand pills. However, names and appearance (shape and color) of medications can be and are always patented and should be treated as the intellectual property. Thus using the name and the shape of the brand pills a manufacturer producing generic medications will be accused of the copyright infringement. This is why generic pills look different, they are of a different color and have a different shape if compared to a brand name pill.
Divalproex sodium affects chemicals in the body that may be involved in causing seizures.
Divalproex 300mg
$1.70
Maxolon
Treating symptoms of gastroesophageal reflux disease (GERD) (heartburn) in patients who do not respond to other...
Metoclopramide 10/15mg
$0.36
Topamax
Treating certain kinds of seizures in patients 2 years of age or older.
Topiramate 25/50/100mg
$0.52
Excellent! I was able to purchase, do the task, and accomplished my time
sensitive objective. Thank You very much. I have recommended your site to my
fellow workers & partners.
- Sincerely, CARLOS
USP Chief Science Officer Darrell Abernethy To Receive ACCP Distinguished Service Award
The U.S. Pharmacopeial (USP) Convention is pleased to announce that its chief science officer, Darrell Abernethy, M.D., Ph.D., will be honored with the American College of Clinical Pharmacology's (ACCP) Nathaniel T. Kwit Memorial Distinguished Service Award at the 2008 ACCP Annual Meeting in Philadelphia, Pa., September 14-16. Dr. Abernethy is being recognized for his lasting contributions to cardiovascular clinical pharmacology. As chief science officer of USP, Dr.
By 2012, Legitimate Generics Will Account For 20% Of Brazil's Pharmaceuticals And Healthcare Market
Research and Markets has announced the addition of the "Brazil Pharmaceuticals and Healthcare Report Q2 2008" report to their offering. The "Brazil Pharmaceuticals and Healthcare Report" provides independent forecasts and competitive intelligence on Brazils pharmaceuticals and healthcare industry. Brazil's pharmaceutical market remains one of the bright spots globally, having posted 17.0% growth in 2007 and reaching an estimated value of US$12.9bn in final consumer prices.
Patent System For Drugs 'Morally Unacceptable'
Major drugs companies are using fierce lobbying tactics to protect a pharmaceutical patent system that is "simply morally unacceptable", a world-leading political philosopher told a major meeting of UK and European pharmacologists.
European Biotech Industry Identifies The Real Culprits Causing Food Price Rises
The European Biotech Industry Association (EuropaBio) questions the premises and the methods used by recent reports, including the recently leaked and unofficial World Bank internal note which claims that 75% of the recent price increase of food is due to increasing demand for biofuel.
